|
STIL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.43218770176645E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.36679994994427E-09 |
| Normal-vs-Stage2 |
3.245700E-02 |
| Normal-vs-Stage3 |
4.13310000000333E-05 |
| Normal-vs-Stage4 |
1.144390E-01 |
| Stage1-vs-Stage2 |
2.834200E-01 |
| Stage1-vs-Stage3 |
1.033750E-02 |
| Stage1-vs-Stage4 |
2.445400E-01 |
| Stage2-vs-Stage3 |
6.327600E-01 |
| Stage2-vs-Stage4 |
4.826000E-01 |
| Stage3-vs-Stage4 |
5.927400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.70029570820429E-11 |
| Normal-vs-AfricanAmerican |
1.049170E-04 |
| Normal-vs-Asian |
9.041700E-02 |
| Caucasian-vs-AfricanAmerican |
9.875400E-01 |
| Caucasian-vs-Asian |
3.526400E-01 |
| AfricanAmerican-vs-Asian |
3.653800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.6484042149948E-11 |
| Normal-vs-Female |
9.63670000464489E-08 |
| Male-vs-Female |
5.137600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.304000E-03 |
| Normal-vs-Extreme_Weight |
1.91040000041554E-07 |
| Normal-vs-Obese |
7.97379999806225E-08 |
| Normal-vs-Extreme_Obese |
6.082100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.068200E-01 |
| Normal_Weight-vs-Obese |
8.814000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.247200E-01 |
| Extreme_Weight-vs-Obese |
2.713700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.094200E-01 |
| Obese-vs-Extreme_Obese |
2.483200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.124500E-03 |
| Normal-vs-Age(41-60Yrs) |
5.07459962939549E-10 |
| Normal-vs-Age(61-80Yrs) |
1.86810000024629E-07 |
| Normal-vs-Age(81-100Yrs) |
1.442780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.523410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.231600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.658370E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.979700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.876290E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.324300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.37060429251346E-11 |
| Normal-VS-Type2 PRCC |
1.221230E-03 |
| Normal-VS-KIRP CIMP |
6.181500E-03 |
| Normal-VS-Unclassified PRCC |
3.38430000024204E-07 |
| Type1 PRCC-VS-Type2 PRCC |
7.844600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.583800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.152800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.197500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.042200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.473700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.159700E-04 |
| Normal-vs-N1 |
1.103970E-03 |
| Normal-vs-N2 |
2.022200E-01 |
| N0-vs-N1 |
1.760390E-02 |
| N0-vs-N2 |
3.273600E-01 |
| N1-vs-N2 |
5.370000E-01 |
|
|
